DMK PHARMACEUTICALS CORPORATION Increase (Decrease) in Other Current Liabilities
DMK PHARMACEUTICALS CORPORATION reported Increase (Decrease) in Other Current Liabilities of -$1.85 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2023-05-15
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other current liabilities for the quarter ending 2022-09-30 was $0.00.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other current liabilities for the quarter ending 2022-06-30 was -$3.70M.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other current liabilities for the quarter ending 2022-03-31 was $1.85M.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.70M derived: sum of 2 quarters · filed 2022-11-14 | -$1.85M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$1.85M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $1.85M 10-Q · filed 2023-05-15 |